You are here: Industry Insights > BioMed X

News List

BioMed X Institute and Merck KGaA, Darmstadt, Germany, Start Second Research Project in Immunology b3cnewswire
March 16, 2022
A German independent research institute, BioMed X, announces today the start of its new research project ‘Regulatory T Cell...
BioMed X Institute and Boehringer Ingelheim Start New Research Project in Brain Sensor Development b3cnewswire
March 01, 2022
German independent research institute BioMed X announces today the start of its new research project ‘Advanced Biomarker Detection for Pharmacological...
BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology B3Cnewswire
February 07, 2022
German independent research institute BioMed X announces today the extension of its collaboration with Merck KGaA, Darmstadt, Germany, in the research project RNA Splicing in Cancer (RSC).
BioMed X Institute Successfully Completes Fourth Project in Oncology in Collaboration with Merck KGaA, Darmstadt, Germany B3Cnewswire
November 03, 2021
German independent research institute BioMed X announces today the successful completion of the research project DNA Damage in Cancer (DDC) in collaboration with Merck KGaA, Darmstadt, Germany.
BioMed X, Janssen Begin Autoimmunity and Drug Delivery Research contractpharma
August 05, 2021
New research groups, PTA and TMI, aim to combat chronic inflammatory diseases and develop oral delivery of macromolar therapeutics.
BioMed X Institute Today Announces Two New Research Groups in Autoimmunity and Drug Delivery in Collaboration with Janssen b3cnewswire
August 03, 2021
German independent research institute BioMed X announces today the start of two new research projects with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
BioMed X and Merck KGaA, Darmstadt, Germany Launch New Research Program in Oncology b3cnewswire
July 06, 2021
BioMed X, a leading independent research institute, announced today the start of its eighth joint research program with Merck KGaA, Darmstadt, Germany.
BioMedX Extends Collaboration with Merck contractpharma
May 18, 2021
Merck will support up to six more research groups at the BioMed X Institute in Heidelberg within the next six years.
BioMed X, Janssen Enter Oral Drug Delivery Alliance contractpharma
January 27, 2021
German independent research institute BioMed X has announced a new research project with Janssen Research & Development LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, which aims to discover novel transport mechanisms in the ...
BioMed X Launches Rapid Antiviral Response Platform contractpharma
May 14, 2020
Aims to develop ultrafast new antiviral drug discovery, development and mass-manufacturing tools for rapid scale-up of new medications.

Previous page 1 2 Next page